- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07219290
- Original rettssak
Lungefunksjon etter kullposisjon
A litter is often needed to extract a person from an austere environment like the wilderness or from confined, urban spaces. A horizontal litter is generally assumed to be better for patient care, but often makes for a more difficult, if not impossible, evacuation from some settings such as confined space rescue, cave rescue, or wilderness rescue when the litter must be moved up or down a cliff with an undercut edge. A litter in a vertical orientation is easier to move in these situations, which may expedite movement towards definitive care. In some wilderness rescue circles, the mantra is that movement IS definitive care. It is already known that lying flat on the ground negatively affects pulmonary function compared to a sitting baseline.1 It is possible that a vertically oriented litter is better for a subset of patients with respiratory issues than a horizontal litter. The investigators hypothesize that pulmonary function measured by FEV1, FVC, and FEV1/FVC, is better in simulated patients in a vertically oriented litter compared to a horizontally oriented one.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Objective To quantify changes in pulmonary function tests (PFTs) based on litter position.
Hypotheses:
- Compared to sitting baseline, all PFTs in the litter will have decreased forced vital capacity (FVC) and 1 second forced expiratory volume (FEV1).
- Compared to lying down, persons straight upright and pitched forward will have better forced vital capacity (FVC) and 1 second forced expiratory volume (FEV1).
- We do not hypothesize any changes in FEV1/FVC.
Study Design This randomized crossover study will use twelve healthy volunteers. All subjects will do baseline sitting pulmonary testing. Experimental order is balanced to avoid any training effects. Choice of sequence will be by random selection of envelope.
Methods Once consented, included subjects will do baseline sitting measurement of FEV1 and FVC which will give FEV1/FVC. Each subject will then be secured in a Ferno-Washington Model 71 litter wearing their own type 2 or 3 harness, or in a UL tested CMC ATOM Global Harness (California Mountain Corporation, Santa Barbara, CA) meeting ANSI Z359.11-2014 and NFPA 1983-2017 standards, if they don't have their own. The person will be secured with double Vs from the litter sides to the harness and footloops supporting them so their weight is on their feet and only minimally on the harness (if vertical). This process is consistent with industry standards for securing a patient in the litter and follows the specific model of the National Cave Rescue Commission.3 See figure 1 Prior to being secured in the litter the patient will do sitting baseline FEV1 and FVC with an NDDD spirograph. Once there is baseline data the subject will be secured in the litter. The investigators will then repeat spirometry, pulse, and blood pressure in a horizontal position (see figure 2), in a vertical position (see figure 3), and pitched slightly forward in a position that results from a Pike and Pivot rigging for raising up past a difficult cliff edge (see figure 4). The subject will get a rest period in their preferred position until pulse returns to within 5 beats of baseline.
Litter suspension will be with a four-legged litter spider when horizontal, with a high bridle tied directly to the litter head for the full vertical position, and from a low bridle in Pike-and-Pivot formation when pitched forward. The litter will be lifted into position with a 3:1 mechanical advantage system tied to an anchor. No matter the position, the lowest point of the litter will be no more than 6 inches off of the ground. The system will be configured for immediate lower for any expressed concern. The PI (RM) is a technical rescue instructor for the National Cave Rescue Commission and Assistant Training Officer-Technical Rescue for Fresno County search and rescue. The Co-PIs (SS and SD) are on the rope team of Fresno County search and rescue. Each is well versed in rope systems, anchor selection, and patient packaging.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
Fresno, California, Forente stater, 93701
- UCSF Fresno
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- 130-310 pounds
Exclusion Criteria:
- Significant cardiac or pulmonary diseae
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Sekvensiell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Flat
Secured in a flat litter |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
|
Aktiv komparator: Vertical
Secured in a vertical litter |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
|
Aktiv komparator: Pitched forward
Secured in a litter leaning forward |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
|
Placebo komparator: Baseline
Sitting baseline pulmonary function |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Forced Vital Capacity
Tidsramme: Immediately
|
Measurable lung volume on expiration |
Immediately
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
FEV1
Tidsramme: Immediately
|
Air volume exhaled in 1 second |
Immediately
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Roger B Mortimer, MD, UCSF - Fresno
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 25-45106
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Deidentified data will be submitted to a statistician
IPD-delingstidsramme
1/1/26 to 6/1/26
Tilgangskriterier for IPD-deling
Roger Mortimer, MD Sarah Davis, DO Sue Spano, MD Amanda Mortimer, PhD
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .